P-glycoprotein and cancer: what do we currently know?
Author:
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference137 articles.
1. Overcoming multidrug resistance in cancer stem cells;Moitra;BioMed Res. Int.,2015
2. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein;Thomas;Cancer Control J. Moffitt Cancer Cent.,2003
3. P-glycoprotein as a drug target in the treatment of multidrug resistant cancer;Lehne;Curr. Drug Targets,2000
4. Mechanisms of multidrug resistance in cancer;Gillet;Methods Mol. Biol.,2010
5. Drug resistance in cancer: an overview;Housman;Cancers,2014
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antitumor evaluation of amaryllidaceae alkaloids on cancer cell lines: A literature review;Electronic Journal of General Medicine;2024-01-01
2. The Sojourn of Polymeric Micelles for Effective Brain Drug Delivery System;Current Drug Delivery;2024-01
3. Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma;Cancer Drug Resistance;2023-12-28
4. Paeoniflorin Induces ER Stress-Mediated Apoptotic Cell Death by Generating Nox4-Derived ROS under Radiation in Gastric Cancer;Nutrients;2023-12-13
5. Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein;Pharmaceutics;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3